This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Paydiant
Alvarez, Jose B.; Williamson, Elizabeth C.; Weber, JamesCase HBS-511065-EMarketingTo maximize their effectiveness, color cases should be printed in color. Kevin Laracey, founder of Paydiant, needed to figure out how to launch a payment processing company with a new technology based on smart phones. Consumers had increasingly turned to electronic payment methods such as credit cards and debit cards to make purchases. Retailers, however, felt that major credit and debit card issuers had too much market power which was leading to...Starting at €8.20
-
Pfizer and AstraZeneca: Marketing an Acquisition (B)
Quelch, John A.; Weber, JamesCase HBS-515008-EMarketingThis (B) case provides a brief description of the outcome of the (A) case.Starting at €5.74
-
Merrill Lynch: Opción Integrada (abreviado)
McFarlan, F. Warren; Weber, JamesCase HBS-304S26MarketingMerrill Lynch, una firma de corretaje de servicio completo con $ 1,5 billones en activos de clientes, está siendo atacada por tanto de descuento y las firmas de corretaje electrónico. Responde con Integrado Choice, una suite de productos diseñados para clientes de captura, desde el do-it-yourself inversor que no quieren usar un intermediario para los clientes que quieren confiar plenamente en un corredor. La estrategia es de alto riesgo y requier...Starting at €8.20
-
Pearson: Efficacy 2.0
Ofek, Elie; Bertini, Marco; Koenigsberg, Oded; Weber, JamesCase HBS-521012-EMarketingPearson, that billed itself as the "world's learning company," faced a host of critical decisions in mid-2020. Several years prior, it had embarked on a new path that put the learner at the heart of the business and committed to a new strategic orientation. The new approach, under the heading of "efficacy," was meant to ensure that products and services were developed with measurable outcomes that mattered to learners in mind; and such offerings ...Starting at €8.20
-
Pfizer and AstraZeneca: Marketing an Acquisition (A)
Quelch, John A.; Weber, JamesCase HBS-515007-EMarketingIn 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in growing sales due to the challenges of developing new drugs. Over the previous decade or more, Pfizer had pursued acquisitions as a way to acquire new drugs, increase sales, and to reduce costs by comb...Starting at €8.20